Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Current Deferred Tax Assets: 2015-2016

  • Wave Life Sciences' Current Deferred Tax Assets rose 1088.89% to $214,000 in Q4 2016 from the same period last year, while for Dec 2016 it was $214,000, marking a year-over-year increase of 1088.89%. This contributed to the annual value of $214,000 for FY2016, which is 1088.89% up from last year.
  • Per Wave Life Sciences' latest filing, its Current Deferred Tax Assets stood at $214,000 for Q4 2016, which was up 830.43% from $23,000 recorded in Q1 2016.
  • Over the past 5 years, Wave Life Sciences' Current Deferred Tax Assets peaked at $214,000 during Q4 2016, and registered a low of $18,000 during Q4 2015.
  • For the 2-year period, Wave Life Sciences' Current Deferred Tax Assets averaged around $79,750, with its median value being $43,500 (2015).
  • Data for Wave Life Sciences' Current Deferred Tax Assets shows a peak YoY spiked of 1,088.89% (in 2016) over the last 5 years.
  • Quarterly analysis of 2 years shows Wave Life Sciences' Current Deferred Tax Assets stood at $18,000 in 2015, then surged by 1,088.89% to $214,000 in 2016.
  • Its last three reported values are $214,000 in Q4 2016, $23,000 for Q1 2016, and $18,000 during Q4 2015.